000 01292 a2200361 4500
005 20250517073429.0
264 0 _c20171215
008 201712s 0 0 eng d
022 _a1476-5829
024 7 _a10.1111/vco.12207
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHoltermann, N
245 0 0 _aThe tyrosine kinase inhibitor toceranib in feline injection site sarcoma: efficacy and side effects.
_h[electronic resource]
260 _bVeterinary and comparative oncology
_cJun 2017
300 _a632-640 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aCat Diseases
_xdrug therapy
650 0 4 _aCats
650 0 4 _aFemale
650 0 4 _aIndoles
_xadverse effects
650 0 4 _aInjections
_xadverse effects
650 0 4 _aMale
650 0 4 _aProtein-Tyrosine Kinases
_xantagonists & inhibitors
650 0 4 _aPyrroles
_xadverse effects
650 0 4 _aSarcoma
_xdrug therapy
650 0 4 _aSoft Tissue Neoplasms
_xdrug therapy
700 1 _aKiupel, M
700 1 _aHirschberger, J
773 0 _tVeterinary and comparative oncology
_gvol. 15
_gno. 2
_gp. 632-640
856 4 0 _uhttps://doi.org/10.1111/vco.12207
_zAvailable from publisher's website
999 _c25627132
_d25627132